UNSPSC 51383305: Felbinac

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C14H12O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 94WNJ5U8L7, chemically known as ljc 10,141 but generally known as felbinac, which bears US NIH Compound Identifier 3332. European Medicines Agency schedules Felbinac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07527MIG.

UNSPSC 51383305 Felbinac is a Commodity code, but the recent state and local procurement activity tagged to it does not reflect pharmaceutical topical anti-inflammatory products as the code nominally describes. Instead, Seminole County, Florida has posted an IFB for naloxone and safe drug deactivation systems—opioid-reversal medication and controlled-substance disposal equipment—which fall outside the felbinac commodity scope. The mismatch signals either a tagging error in the procurement notice or a misalignment between the code and what state and local governments are actually buying under this designation.

The single recent opportunity on record is Seminole County's IFB 60459723LAS, posted June 30, 2026 with a response deadline of July 26, 2023 (a date inconsistency in the source itself), for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The procurement includes a two-year initial term with one-year renewal option, drug-free workplace and E-Verify compliance requirements, and potential FEMA funding with associated federal environmental compliance obligations. No explicit set-aside or disadvantaged-enterprise designations apply. Beyond this single posting, the code shows no other recent state and local contract activity in the source.